Table 1 Relationship between DARS2 expression and patients features
Characteristic | DARS2Low | DARS2High | p |
|---|---|---|---|
n | 18 | 44 | Â |
Gender, n (%) | 0.593 | ||
 Female | 11 (17.7%) | 30 (48.4%) |  |
 Male | 7 (11.3%) | 14 (22.6%) |  |
Age (years), n (%) | 0.517 | ||
 < 60 | 13 (21%) | 28 (45.2%) |  |
 ≥ 60 | 5 (8.1%) | 16 (25.8%) |  |
Differential, n (%) | 0.010 | ||
 High/moderately | 16 (25.8%) | 24 (38.7%) |  |
 Poorly | 2 (3.2%) | 20 (32.3%) |  |
T stage, n (%) | 0.167 | ||
 T1 | 16 (25.8%) | 32 (51.6%) |  |
 T2–T4 | 2 (3.2%) | 12 (19.4%) |  |
N stage, n (%) | 0.007 | ||
 N0 | 16 (25.8%) | 23 (37.1%) |  |
 N1–N3 | 2 (3.2%) | 21 (33.9%) |  |
TNM stage, n (%) | 0.023 | ||
 I | 15 (24.2%) | 23 (37.1%) |  |
 I–III | 3 (4.8%) | 21 (33.9%) |  |